ADMP

Adamis Pharmaceuticals (ADMP)

Adamis Pharmaceuticals Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:ADMP
DateTimeSourceHeadlineSymbolCompany
07/19/20214:07PMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/19/20214:05PMBusiness WireAdamis Announces Results of 2021 Annual Meeting of Stockholders NASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/13/20218:28AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a) NASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/13/20218:00AMBusiness WireAdamis Urges Stockholders to Vote to Reelect the Company’s Board of Directors at Upcoming Annual Meeting on Friday, July 16th NASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/13/20216:04AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a) NASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/13/20216:04AMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/01/20218:21AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a) NASDAQ:ADMPAdamis Pharmaceuticals Corporation
07/01/20218:00AMBusiness Wire Adamis Sends Letter to Stockholders to Address Jerald A. Hammann’s Costly, Distracting and Misguided Campaign NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/28/20217:32AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a) NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/28/20217:00AMBusiness WireAdamis Sends Letter to Stockholders Regarding Its Strategic Focus on Tempol as a Potentially Potent Treatment for COVID-19 NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/14/202110:32AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a) NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/14/20219:00AMBusiness WireAdamis Files Definitive Proxy Statement and Sends Letter to Stockholders NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/14/20216:03AMEdgar (US Regulatory)Proxy Statment - Contested Solicitations (definitive) (defc14a) NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/11/20218:33AMSeeking AlphaAdamis begins clinical trial start-up activities for COVID drug; shares rise 5% NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/11/20217:30AMGlobeNewswire Inc.Adamis Provides Update on Clinical Trial Start-Up Progress for Tempol in the Treatment of COVID-19 NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/09/20217:46AMSeeking AlphaAdamis Pharma soars 18% after FDA accepts Zimhi application for review NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/09/20217:30AMGlobeNewswire Inc.Adamis Provides Update on ZIMHI™ NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/07/20217:30AMGlobeNewswire Inc.Adamis Highlights National Institute of Health Study Identifying Tempol as a Potential Antiviral Drug for COVID-19 NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/02/20215:37PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3) NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/02/20218:20AMEdgar (US Regulatory)Additional Proxy Soliciting Materials - Non-management (definitive) (dfan14a) NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/01/20214:37PMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:ADMPAdamis Pharmaceuticals Corporation
06/01/20217:30AMGlobeNewswire Inc.Adamis Pharmaceuticals Provides Business Update NASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/28/20214:09PMSeeking AlphaAdamis pharmaceuticals gets deficiency letter from NASDAQ NASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/28/20214:04PMGlobeNewswire Inc.Adamis Pharmaceuticals Announces Receipt of Deficiency Letter from NASDAQ NASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/27/20215:12PMEdgar (US Regulatory)Current Report Filing (8-k) NASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/24/20215:22PMEdgar (US Regulatory)Amended Notification That Quarterly Report Will Be Submitted Late (nt 10-q/a) NASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/17/20214:17PMEdgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q) NASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/17/20214:05PMGlobeNewswire Inc.Adamis Pharmaceuticals Provides Update on First Quarter 2021 Financial Results Conference Call NASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/17/20217:45AMSeeking AlphaAdamis resubmits ZIMHI opioid overdose treatment NDA NASDAQ:ADMPAdamis Pharmaceuticals Corporation
05/17/20217:30AMGlobeNewswire Inc.Adamis Pharmaceuticals Resubmits ZIMHI New Drug Application to FDA for the Treatment of Opioid Overdose NASDAQ:ADMPAdamis Pharmaceuticals Corporation
 Showing the most relevant articles for your search:NASDAQ:ADMP
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20210730 08:46:38